Veterinary Medicines

Gallivac Reo liofilizāts un šķīdinātājs suspensijas injekcijām pagatavošanai vistām

Not authorised
  • Avian reovirus, strain S1133, Live
Download as PDF

Product identification

Medicine name:
Gallivac Reo liofilizāts un šķīdinātājs suspensijas injekcijām pagatavošanai vistām
Active substance:
  • Avian reovirus, strain S1133, Live
Target species:
  • Chicken (for reproduction)
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Avian reovirus, strain S1133, Live
    10000.00
    50% tissue culture infectious dose
    /
    1.00
    unit(s)
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Chicken (for reproduction)
      • Not specified
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD10
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Latvia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health Italia S.p.A. In Breve Boehringer Ingelheim Ah It S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health Italia S.p.A. In Breve Boehringer Ingelheim Ah It S.p.A.
Responsible authority:
  • Food And Veterinary Service
Authorisation number:
  • V/NRP/01/1328
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 24/04/2024
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 24/04/2024
Download